BIBLIOS

  Ciências References Management System

Visitor Mode (Login)
Need help?


Back

Publication details

Document type
Journal articles

Document subtype
Full paper

Title
Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives

Participants in the publication
Soraia C. Abreu (Author)
Miquéias Lopes-Pacheco (Author)
Dep. Química e Bioquímica
BIOISI - Instituto de Biossistemas e Ciências Integrativas
Daniel J. Weiss (Author)
Patricia R. M. Rocco (Author)

Scope
International

Refereeing
Yes

Summary
Extracellular vesicles (EVs) have emerged as a potential therapy for several diseases. These plasma membrane-derived fragments are released constitutively by virtually all cell types-including mesenchymal stromal cells (MSCs)-under stimulation or following cell-to-cell interaction, which leads to activation or inhibition of distinct signaling pathways. Based on their size, intracellular origin, and secretion pathway, EVs have been grouped into three main populations: exosomes, microvesicles (or microparticles), and apoptotic bodies. Several molecules can be found inside MSC-derived EVs, including proteins, lipids, mRNA, microRNAs, DNAs, as well as organelles that can be transferred to damaged recipient cells, thus contributing to the reparative process and promoting relevant anti-inflammatory/resolutive actions. Indeed, the paracrine/endocrine actions induced by MSC-derived EVs have demonstrated therapeutic potential to mitigate or even reverse tissue damage, thus raising interest in the regenerative medicine field, particularly for lung diseases. In this review, we summarize the main features of EVs and the current understanding of the mechanisms of action of MSC-derived EVs in several lung diseases, such as chronic obstructive pulmonary disease (COPD), pulmonary infections [including coronavirus disease 2019 (COVID-19)], asthma, acute respiratory distress syndrome (ARDS), idiopathic pulmonary fibrosis (IPF), and cystic fibrosis (CF), among others. Finally, we list a number of limitations associated with this therapeutic strategy that must be overcome in order to translate effective EV-based therapies into clinical practice.

Date of Submisson/Request
2020-08-30
Date of Acceptance
2021-01-11
Date of Publication
2021-02-15

Institution
FACULDADE DE CIÊNCIAS DA UNIVERSIDADE DE LISBOA

Where published
Frontiers in Cell and Developmental Biology

Publication Identifiers

Publisher
Frontiers Media SA

Volume
9
Number
600711

Document Identifiers
DOI - https://doi.org/10.3389/fcell.2021.600711
URL - http://dx.doi.org/10.3389/fcell.2021.600711

Download

Export

APA
Soraia C. Abreu, Miquéias Lopes-Pacheco, Daniel J. Weiss, Patricia R. M. Rocco, (2021). Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives. Frontiers in Cell and Developmental Biology, 9,http://dx.doi.org/10.3389/fcell.2021.600711

IEEE
Soraia C. Abreu, Miquéias Lopes-Pacheco, Daniel J. Weiss, Patricia R. M. Rocco, "Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives" in Frontiers in Cell and Developmental Biology, vol. 9, 2021. 10.3389/fcell.2021.600711

BIBTEX
@article{49506, author = {Soraia C. Abreu and Miquéias Lopes-Pacheco and Daniel J. Weiss and Patricia R. M. Rocco}, title = {Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives}, journal = {Frontiers in Cell and Developmental Biology}, year = 2021, volume = 9 }